Immuron IMRN
NASDAQ IMRN
$0.95 -0.02 (-2.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Selling, General & Administrative (2019 - 2024)

Updated

Immuron (IMRN) reported Selling, General & Administrative of -$4.31 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Selling, General & Administrative (2019 - 2024) Analysis & Trends

Dating back to FY2015, Immuron's Selling, General & Administrative record includes 12 fiscal years.

  • Five-year annual Selling, General & Administrative spans a low of -$4.48 million in FY2025 and a high of $1.95 million in FY2023.
  • According to Business Quant data, Selling, General & Administrative came in at -$4.48 million in FY2025, -$45,557 in FY2024, $1.95 million in FY2023 (+4.8%) and $1.86 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.63 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.92 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.41 Bn
10 Immuron 7.67 Mn -9.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.98 Mn
Sep 9, 2024 -30,356.40
Dec 31, 2023 -27,477.69
Sep 1, 2020 70,000.00
Aug 30, 2019 70,000.00
API Access

Immuron Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IMRN&period=max&api_key=YOUR_API_KEY